Rosiglitazone for type 2 diabetes mellitus

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1999年 / 41卷 / 1059期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：71 / +
页数：3
相关论文
共 50 条
  • [21] The Effect of Rosiglitazone on the Expression of Thrombogenic Markers on Leukocytes in Type 2 Diabetes Mellitus
    Svobodova, H.
    Stulc, T.
    Kasalova, Z.
    Dolezalova, R.
    Marinov, I.
    Capek, P.
    Ceska, R.
    PHYSIOLOGICAL RESEARCH, 2009, 58 (05) : 701 - 707
  • [22] Mechanisms by which rosiglitazone improves glycemic control in type 2 diabetes mellitus
    Dostou, JM
    Islam, N
    Meyer, C
    Woerle, HJ
    Sparks, C
    Sparks, J
    Wittlin, S
    Dabiri, GA
    Anderson, AB
    Gerich, J
    DIABETES, 2001, 50 : A513 - A513
  • [23] Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus
    Patrizio Tatti
    Franco Arrigoni
    Adriano Longobardi
    Flavia Costanza
    Patrizia Di Blasi
    Domenico Merante
    Clinical Drug Investigation, 2008, 28 : 327 - 332
  • [24] Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus
    Tatti, Patrizio
    Arrigoni, Franco
    Longobardi, Adriano
    Costanza, Flavia
    Di Blasi, Patrizia
    Merante, Domenico
    CLINICAL DRUG INVESTIGATION, 2008, 28 (05) : 327 - 332
  • [25] Anti-inflammatory effects of rosiglitazone in type 2 diabetes mellitus patients
    van Doorn, MBA
    Kemme, M
    Ouwens, M
    van Hoogdalem, EJ
    Liu, X
    Li, QS
    de Kam, ML
    Burggraaf, J
    Cohen, AF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (06) : 680 - 680
  • [26] The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus
    Guldiken, S
    Turgut, B
    Demir, M
    Arikan, E
    Kara, M
    Vural, O
    Tugrul, A
    Fareed, J
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (01) : 55 - 60
  • [27] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [28] The anti-inflammatory effects of rosiglitazone in patients with type 2 diabetes mellitus
    Kadoglou, N. P.
    Iliadis, F.
    Liapis, C. D.
    Perrea, D.
    Didangelos, I. P.
    Tsanikidis, H.
    Alevizos, M.
    DIABETOLOGIA, 2007, 50 : S260 - S260
  • [29] Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries, Corinne S.
    Russell-Jones, David L.
    BRITISH MEDICAL JOURNAL, 2009, 339
  • [30] The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus
    Ko, SH
    Song, KH
    Ahn, YB
    Yoo, SJ
    Son, HS
    Yoon, KH
    Cha, BY
    Lee, KW
    Son, HY
    Kang, SK
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (06): : 731 - 734
12345